Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk

INTRODUCTION: Lung cancer is the world’s leading cause of cancer death. Low-dose computed tomography (LDCT) screening reduced lung cancer mortality by 20% in the US National Lung Screening Trial. Here, we present the Yorkshire Lung Screening Trial (YLST), which will address key questions of relevanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Crosbie, Philip AJ, Gabe, Rhian, Simmonds, Irene, Kennedy, Martyn, Rogerson, Suzanne, Ahmed, Nazia, Baldwin, David R, Booton, Richard, Cochrane, Ann, Darby, Michael, Franks, Kevin, Hinde, Sebastian, Janes, Sam M, Macleod, Una, Messenger, Mike, Moller, Henrik, Murray, Rachael L, Neal, Richard D, Quaife, Samantha L, Sculpher, Mark, Tharmanathan, Puvanendran, Torgerson, David, Callister, Matthew EJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485242/
https://www.ncbi.nlm.nih.gov/pubmed/32912947
http://dx.doi.org/10.1136/bmjopen-2020-037075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485242/
https://www.ncbi.nlm.nih.gov/pubmed/32912947
http://dx.doi.org/10.1136/bmjopen-2020-037075

Ejemplares similares